Merck has informed that a meeting of the Board of Directors of the Company will be held on January 31, 2014 to consider and approve the Audited Financial Results for the quarter & year ended December 31, 2013 and to consider recommendation of dividend for the year 2013.
The above information is a part of company’s filings submitted to BSE.